amitriptyline has been researched along with Pulmonary Hypertension in 2 studies
Amitriptyline: Tricyclic antidepressant with anticholinergic and sedative properties. It appears to prevent the re-uptake of norepinephrine and serotonin at nerve terminals, thus potentiating the action of these neurotransmitters. Amitriptyline also appears to antagonize cholinergic and alpha-1 adrenergic responses to bioactive amines.
amitriptyline : An organic tricyclic compound that is 10,11-dihydro-5H-dibenzo[a,d][7]annulene substituted by a 3-(dimethylamino)propylidene group at position 5.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| GUILLAMONALCANTARA, A | 1 |
| Teisberg, P | 1 |
| Hognestad, J | 1 |
2 other studies available for amitriptyline and Pulmonary Hypertension
| Article | Year |
|---|---|
[TREATMENT OF MENTAL DISORDERS IN DECOMPENSATED COR PULMONALE WITH AMITRIPTYLINE].
Topics: Amitriptyline; Chronic Disease; Drug Therapy; Humans; Hypertension, Pulmonary; Mental Disorders; Pul | 1964 |
Primary pulmonary hypertension in infancy.
Topics: Amitriptyline; Autopsy; Female; Humans; Hypertension, Pulmonary; Infant; Infant, Newborn; Lung; Male | 1973 |